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Background: The administration of cisplatin is limited due to its nephrotoxic side effects, and prevention of this
nephrotoxicity of cisplatin is difficult. Mesenchymal stem cell (MSC)-derived exosomes have been implicated as
a novel therapeutic approach for tissue injury. In this study, we demonstrated that the pretreatment of human
umbilical cord MSC-derived exosomes (hucMSC-Ex) can prevent the development of cisplatin-induced renal
toxicity by activation of autophagy in vitro and in vivo.
Methods: In vitro, rat renal tubular epithelial (NRK-52E) cells were pre-incubated with exosomes from hucMSC
or HFL1 (human lung fibroblast cells; as control) for 30 min, and 3-methyladenine (an autophagic inhibitor) and
rapamycin (an autophagic inducer) for 1 h before cisplatin treatment for 8 h, respectively. Cells were harvested
for apoptosis assay, enzyme-linked immunosorbent assay (ELISA), Western blot, and quantitative real-time
polymerase chain reaction (qRT-PCR). In vivo, we constructed cisplatin-induced acute kidney injury rat models.
Prior to treatment with cisplatin for 0.5 h, hucMSC-Ex or HFL1-Ex were injected into the kidneys via the renal
capsule. 3-methyladenine and rapamycin were injected under the kidney capsule before hucMSC-Ex. All animals
were sacrificed at 3 days after cisplatin injection. Renal function, Luminex assay, tubular apoptosis and proliferation,
and autophagy response were evaluated.
Results: hucMSC-Ex inhibited cisplatin-induced mitochondrial apoptosis and secretion of inflammatory cytokines
in renal tubular epithelial cells in vitro. hucMSC-Ex increased the expression of the autophagic marker protein LC3B
and the autophagy-related genes ATG5 and ATG7 in NRK-52E cells. Rapamycin mimicked the effects of hucMSC-Ex
in protecting against cisplatin-induced renal injury, while the effects were abrogated by the autophagy inhibitor
3-methyladenine in the animals.
Conclusions: Our findings indicate that the activation of autophagy induced by hucMSC-Ex can effectively relieve
the nephrotoxicity of cisplatin. Therefore, pre-treatment of hucMSC-Ex may be a new method to improve the
therapeutic effect of cisplatin.
Keywords: Human umbilical cord mesenchymal stem cell, Exosome, Cisplatin, Nephrotoxicity, Autophagy* Correspondence: lstmmmlst@163.com; icls@ujs.edu.cn
†Equal contributors
1Key Laboratory of Laboratory Medicine of Jiangsu Province, School of
Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu 212013,
People’s Republic of China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wang et al. Stem Cell Research & Therapy  (2017) 8:75 Page 2 of 14Background
Cisplatin is a platinum inorganic complex, extensively
used in clinical chemotherapy for many solid tumors.
Administration of a high dose of cisplatin is limited due
to its nephrotoxic side effects [1, 2]. Therefore, prevent-
ive measures are needed to counteract the renal damage
induced by cisplatin. It is now recognized that exo-
somes/microvesicles as nanoparticles are an integral part
of the intercellular microenvironment [3], and may play
a pivotal role in cell-to-cell communication [4]. Micro-
vesicles (MVs) are circular fragments of membrane re-
leased from the endosomal compartment as exosomes
or shed from the surface membranes of most cell types.
Exosomes/microvesicles may interact with target cells
by surface-expressed ligands and transfer surface recep-
tors, and deliver proteins, mRNA, and bioactive lipids
between cells [5, 6]. Recently, many studies have revealed
that mesenchymal stem cell (MSC)-derived exosomes or
microvesicles can promote tissue regeneration. MVs from
human bone marrow-derived MSCs contribute to favor
functional and morphological recovery in rodent models
of acute kidney injury (AKI) induced by glycerol [7], ische-
mia/reperfusion [8], and cisplatin [9]. The research implies
that exosomes from MSCs may be a novel stem cell-based
therapy for kidney diseases. Our previous works indicate
that human umbilical cord-derived MSCs (hucMSCs)
improve the recovery of ischemia/reperfusion-induced rat
renal injury via anti-apoptotic and anti-inflammatory
mechanisms [10–12]. We also demonstrated that
hucMSC-derived exosomes (hucMSC-Ex) protect against
cisplatin-induced renal oxidative stress and apoptosis,
alleviate CCl4-induced liver fibrosis, and enhance cutane-
ous wound healing [13–17]. All the above studies show
that hucMSC-Ex can improve the tissue injury. However,
it is unknown whether hucMSC-Ex administration before
injury can prevent kidney damage in the early stages.
Studies have demonstrated that autophagy is critical
for normal proximal tubule function and protection
against acute tubular injury [18, 19]. There is a dynamic
feedback between autophagy and cellular energy balance
[20]. Autophagy not only plays a principal role in the
supply of nutrients for cell survival, but also plays an
active role in cellular homeostasis, where it acts as a
cytoplasmic quality-control regulator to eliminate long-
lived or unfolded proteins and damaged organelles
[21, 22]. These reports revealed that the activation of
autophagy plays an important role in relieving tissue
damage. Whether hucMSC-Ex can promote autophagy
activation is unclear.
Herein, we show that hucMSC-Ex had a markedly pre-
ventative effect against cisplatin-induced renal toxicity,
and we explored the mechanism of action. Our findings
indicate that hucMSC-Ex promoted autophagy in renal
tubule epithelial cells and kidney tissues by cisplatininduced through the inhibition of mTOR, thus alleviat-
ing cell apoptosis and inflammatory response in the early
stages.
Methods
The study was approved by the ethical committee of
Jiangsu University (2012258).
Isolation and culture of hucMSCs
After obtaining parental and ethics committee consent,
the fresh umbilical cords were collected and processed
within 6 h as described previously [23]. Umbilical cords
were cut into pieces and floated in low glucose Dulbecco’s
modified Eagle’s medium (LG-DMEM) containing 10%
fetal bovine serum (FBS; ExCell Biology, China) and 1%
penicillin and streptomycin. Cord pieces were subse-
quently incubated at 37 °C in humid air with 5% CO2.
When well-developed colonies of fibroblast-like cells
reached 80% confluency, cultures were trypsinized into
new flasks for further expansion. hucMSCs were identified
by fluorescence-activated cell sorting (FACS) and differen-
tiation experiments.
FACS analysis and differentiation studies of hucMSCs
hucMSCs were resuspended in phosphate-buffered saline
(PBS). Cell aliquots (300 μl) were incubated with fluor-
escein isothiocyanate (FITC)-conjugated or phycoeryth-
rin (PE)-conjugated monoclonal antibodies specific for
CD13, CD29, CD44, CD90, CD105, HLA-1, CD45,
HLA-DR, and CD34 on ice for 30 min. FITC or PE
mouse nonimmune isotypic IgG were used as controls.
All antibodies were purchased from BD Company. The
pluripotency of hucMSCs was confirmed by their ability
to differentiate into osteocytes and adipocytes, as described
previously [23].
Isolation and characterization of exosomes from hucMSCs
and HFL1 cells
As control cells, human fetal lung fibroblast-1 (HFL1)
cells were obtained from Cell Bank, Type Culture Col-
lection Committee, the Chinese Academy of Sciences
(Shanghai, China). In order to allow exosome separation,
HFL1 cells were cultured with serum-free α-modified
minimum essential medium (α-MEM); hucMSCs were
cultured with serum-free LG-DMEM. The conditioned
medium was collected at 48 h. Density gradient centrifu-
gations were executed and the procedure for the extrac-
tion and purification of exosomes was performed as
described previously [13, 14]. The purified exosomes
were stored at –86 °C until use. The expression of the
exosomal makers CD81, CD9, and CD63 was detected
using Western blot. The purified exosomes were further
identified by nanoparticle tracking analysis (NTA) system
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NTA and transmission electron microscopy
In order to analyze the characteristics of the exosomes,
particle size, substantial shape, and the relative-intensity
three-dimensional plot of hucMSC-Ex were tested using
the NTA system. The purified hucMSC-Ex were applied
to glow-discharged carbon-coated copper grids to detect
the precise shape. PTA (phosphor-tungsten acid) staining
was conducted for 30 min. The grids were then rinsed
with droplets of deionized water and dried. Ultra-thin
sections of NRK-52E cells were prepared to observe the for-
mation of autophagic bodies. Transmission electron micro-
graphs were recorded using a Tecnai 12 (Philips, Holland).
In vitro experiment
Normal rat kidney epithelial (NRK-52E) cells were
obtained from Cell Bank (Shanghai, China). NRK-52E cells
were pre-incubated with exosomes from hucMSC (200
μg/ml) or exosomes from HFL1 (200 μg/ml) for 30 min,
followed by treatment with cisplatin (8 μM) for 8 h. 3-
methyladenine (3MA; 1 mg/ml; Sigma, USA) or rapamy-
cin (200 μg/ml; Sigma) was given for 0.5 h before exo-
somes treatment and 1 h before cisplatin treatment in
NRK-52E cells, respectively.
In vivo rat model
Female Sprague-Dawley rats at 6–8 weeks old, weighing
210–250 g, were used. The animals were kept under
standard laboratory conditions (12 h light/12 h dark
cycle, and 21 ± 2 °C). Animals were divided into seven
groups of six rats each and treated as follows: 1) control
group (no cisplatin treatment); 2) PBS group (intraperi-
toneal injection of a single dose of 5 mg/kg cisplatin); 3)
hucMSC-Ex group (0.5 h before cisplatin administration
both kidneys in one rat received a renal capsule injection
of 200 μg hucMSC-Ex); 4) HFL1-Ex group (0.5 h before
cisplatin administration both kidneys in one rat received a
renal capsule injection of 200 μg HFL1-Ex); 5) hucMSC-
Ex + 3MA group (500 μg/kidney 3MA was injected under
the kidney capsule before hucMSC-Ex and cisplatin
administration); 6) 3MA group (500 μg/kidney 3MA was
injected under the kidney capsule before cisplatin
administration); and 7) Rapa group (20 μg/kidney 3MA
was injected under the kidney capsule before cisplatin
administration).
All animals were sacrificed at 3 days after cisplatin in-
jection. Kidney tissue specimens were divided into two.
One was quickly excised, rinsed in ice-cold saline, and
fixed in 4% paraformaldehyde, and the paraffin-
embedded tissues were sliced and stained with
hematoxylin and eosin (H&E). Sections were analyzed
and at least 20 random fields were scored by anephropathologist in a blinded manner. Tubular cell ne-
crosis, tubular dilation, and tubular protein casts (200×
magnification) in sections were observed and analyzed.
Abnormalities were graded by a semiquantitative score
from 0 to 4: 0, no abnormalities; 1, changes affecting less
than 25% of the sample; 2, changes affecting 25 to 50%;
3, changes affecting 50 to 75%; 4, changes affecting more
than 75%. The other specimen was used immediately or
frozen at –86 °C until further biochemical analysis. Blood
samples were collected before and after cisplatin injection
(0, 1, 2, and 3 days). Serum creatinine (Cr) and blood urea
nitrogen (BUN) levels were measured by an automatic
biochemical analyzer (AU2700; Olympus). Serum levels of
inflammatory cytokines such as tumor necrosis factor
(TNF)-α, interleukin (IL)-1β and IL6 were determined by
Luminex assays (Luminex 200; Millipore).
Mitochondrial membrane potential assay
NRK-52E cells seeded in 24-well plates were treated as
described for the in vitro experiment. After treatment
with cisplatin for 8 h, the cells were fixed with 4% para-
formaldehyde. Mitochondrial membrane potential was
measured by a JC-1 kit according to the manufacturer’s
protocol (Beyotime, China).
RNA extraction and quantitative real-time PCR
Total RNA was extracted with Trizol reagent (Invitrogen,
USA) from NRK-52E cells and kidney tissues; cDNA was
synthesized using a reverse transcription kit according
to the manufacturer’s instructions (Vazyme, China).
Quantitative real-time polymerase chain reaction (qRT-
PCR) was used to detect the expression of ATG5,
ATG7, and β-actin genes. All samples were examined
in triplicate, and all reactions were repeated three times
independently using the CFX96 Touch™ Real-Time
PCR Detection System (Bio-Rad, USA).
TUNEL assay
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) staining was used to detect
the apoptotic cells. hucMSCs, HFL1 cells, NRK-52E cells,
and the kidney tissues were examined using the TdT-
FragEL DNA fragmentation detection kit according to the
manufacturer's protocol (Boster, China). Positive cells
were identified as dark brown nuclei under a light micro-
scope (Nikon eclipse TE 3000-U, Japan). The number of
apoptotic cells was counted in 20 randomly selected visual
fields of blinded samples, at 200× magnification.
Western blot
Cells, exosomes, and tissues were lysed in RIPA buffer.
Protein concentration was determined using the BCA
assay kit (Pierce, USA). Sources and dilution factors of pri-
mary antibodies were: rabbit polyclonal CD63 (1:1000;
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Epitomics, USA), PCNA (1:1000; Bioworld), BCL-XL
(1:100; SAB, USA), BCL-2 (1:1000; Bioworld), Bax (1:1000;
Bioworld), Cytochrome C (1:500; Abcam, USA), caspase-3
(1:500; Bioworld), IL-1β (1:500; Bioworld,), LC3B (1:500;
Abcam), Beclin-1 (1:600; Proteintech, USA), mTOR
(1:500; SAB), p-mTOR (1:500; SAB), 4EBP1 (1:200; SAB),
p70S6K (1:200; SAB), and mouse monoclonal GAPDH
(1:3000; Kang Chen, China). The nucleoprotein and
plasma protein was separated by the nuclear and plasma
protein isolation kit (Vazyme, China), with the primary
antibody NF-kB-P65 in the nucleus (1:500; SAB), primary
antibody nucleoprotein Histone (1:1000; SAB). After incu-
bation with the primary antibodies overnight at 4 °C,
membranes were washed three times with Tris-buffered
saline with 0.05% Tween-20 and challenged with HRP-
conjugated goat anti-rabbit or goat anti-mouse antibody
(1:2000; Bioworld). Western blot was performed by
Luminata™ crescendo western HRP substrate (Millipore,
USA) and analyzed using MD Image Quant Software.
Immunocytochemistry and immunohistochemistry
NRK-52E cells, treated as described for the in vitro
experiment, were fixed in 4% paraformaldehyde and
permeabilized with HEPES-Triton X100 buffer. The
paraffin-embedded kidney tissue sections were dewaxed.
Endogenous peroxidase activity was then inhibited by
exposure to 3% hydrogen peroxide for 10 min. Subse-
quently, the sections were boiled for 10 min in citrate buf-
fer (pH 6.0, 10 mM) for antigen retrieval. The sections
were then blocked with 5% BSA (Boster Bioengineering,
Co. Ltd., Wuhan, China) and incubated with TNF-α
(1:100; Bioworld) and PCNA (1:100; Bioworld) primary
antibody at 37 °C for 1 h. After the sections were washed
with PBS, they were then incubated with diluted secondary
antibody for 20 min. Finally, cells were visualized using di-
aminobenzidine (DAB) substrate and counterstained with
hematoxylin for microscopic examination. The number of
PCNA-positive cells were counted in 20 randomly selected
visual fields of blinded samples, at 200× magnification.
Enzyme-linked immunosorbent assay
NRK-52E cells were treated as mentioned above. Culture
supernatants were collected and cell debris was removed
by centrifugation. Supernatants were examined using the
rat TNF-α enzyme-linked immunosorbent assay (ELISA)
kit according to the manufacturer's protocol (ExCell
Biology, China).
Luminex assay
Female Sprague-Dawley rats were treated as mentioned
above. The serum inflammatory cytokines TNF-α, IL-1β, and
IL6 were measured using Luminex kits (Millipore, Billerica,
MA, USA) according to the manufacturer’s instructions.Cell transfection and structured illumination
microscopy assay
NRK-52E cells were seeded in 24-well plates and cultured
for 24 h, then transfected with mRFP-GFP-LC3 adeno-
virus according to the manufacturer's protocol (Han Heng
Biology, China). Then, cells were cultured on coverslips
and divided into four groups: control; PBS; pre-treated
hucMSC-Ex; and pre-treated HFL1-Ex. After treatment,
the cells were washed with PBS, fixed with 4% paraformal-
dehyde, and permeabilized with HEPES-Triton X100 buf-
fer. Finally, the cells were stained with Hoechst33342 for
nuclear staining, and the images were acquired with a
structured illumination microscopy (Nikon, SIM).
Statistical analysis
All data from different experiments are expressed as
mean ± SD. Statistical analysis was performed by
Student’s t test or by analysis of variance (ANOVA)
with Newmann-Keuls multicomparison or Dunnett’s
post hoc tests as appropriate. A two-tailed P value
<0.05 was considered statistically significant.
Results
Characterization of hucMSC and hucMSC-Ex
MSCs isolated from the umbilical cord were characterized
by FACS analysis (see Additional file 1: Figure S1A) and
induced differentiation (Additional file 1: Figure S1B and
C). Exosomes were extracted and purified from hucMSC
and were identified by morphology and exosomal markers.
The particle size and concentration of exosomes were
measured by an NTA system, peaking at 102 nm diameter
(see Additional file 2: Figure S2Aa), a relative-intensity
three-dimensional plot (shown in Additional file 2: Figure
S2Ab), and electron micrograph of phosphotungstanic
acid-stained exosomes (Additional file 2: Figure S2Ac).
The results of transmission electron microscopy showed
that the hucMSC-Ex had a fingerprint-like membrane
structure (Additional file 2: Figure S2Ba) and a spheroid
shape (Additional file 2: Figure S2Bb). The purified
hucMSC-Ex expressed exosomal marker proteins such as
CD81, CD9, and CD63 (Additional file 2: Figure S2C).
TUNEL stain showed that the number of apoptotic cells
was not significantly different between normal cultured
conditions and serum-free cultured conditions at 48 h
(Additional file 2: Figure S2D). Electron microscope exam-
ination showed that hucMSC-Ex expressed CD9 colloidal
gold (Additional file 2: Figure S2E).
hucMSC-Ex can prevent cisplatin-induced AKI in vivo
We determined whether hucMSC-Ex could prevent AKI
in rats. Rats were divided into four groups (n = 6 per
group) as follows: 1) control group (rats were treated
with PBS intraperitoneally); 2) PBS group (rats were
injected with intraperitoneal cisplatin at 5 mg/kg body
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fore treatment with cisplatin); 3) hucMSC-Ex group
(hucMSC-Ex (200 μg/kidney) were injected under bilat-
eral renal capsules before treatment with cisplatin); and
4) HFL1-Ex group (HFL1-Ex (exosomes derived from
HFL1, as a control for hucMSC-Ex; 200 μg/kidney) was
injected under the kidney capsule before treatment with
cisplatin. All animals were sacrificed at 3 days after cis-
platin injection. Representative images of H&E staining
showed that the number of renal tubules with edema
and structural damage were significantly reduced in the
hucMSC-Ex group (Fig. 1a and b). The number of PCNA-
positive cells was higher in hucMSC-Ex group compared
to the PBS and HFL1-Ex groups (Fig. 1c and d). In
contrast, the number of TUNEL-positive cells was lower
in the hucMSC-Ex group compared to the PBS and
HFL1-Ex groups (Fig. 1e and f). We also measured the
serum creatinine (Cr) and blood urea nitrogen (BUN)
levels at different times after cisplatin injection. We found
that cisplatin led to a sharp increase in both Cr and BUN
levels at 3 days after injection. Treatment with hucMSC-Ex
significantly decreased Cr and BUN levels (Fig. 1g and h).
In summary, these results indicate that hucMSC-Ex pro-
tects against renal injury induced by cisplatin, but there is
no similar preventive action in the HFL1-Ex group.
hucMSC-Ex inhibits cisplatin-induced apoptosis and
inflammatory response in vitro
To determine whether hucMSC-Ex prevents renal tu-
bule epithelial cells from cisplatin-induced apoptosis and
secretion of inflammatory cytokines, NRK-52E cells (rat
kidney epithelial cells) were treated as described for the
in vitro experiment. Mitochondrial membrane potential
is considered a sensitive measurement of early apoptosis.
Compared with the control group (NRK-52E cells
without cisplatin), cisplatin reduced the mitochondrial
membrane potential. hucMSC-Ex, but not HFL1-Ex,
treatment antagonized the cisplatin-induced decrease in
mitochondrial membrane potential (Fig. 2a). We also
confirmed the effect of hucMSC-Ex on cisplatin-induced
apoptosis using the TUNEL assay. As shown in Fig. 2b
and c, the number of TUNEL-positive cells, identified as
dark brown nuclei, was lower in the hucMSC-Ex group
than that in the PBS and HFL1-Ex groups. After treat-
ment with hucMSC-Ex, the expression of apoptosis-
related proteins such as Bax, Cytochrome c, and
cleaved Caspase-3 decreased, but the expression of pro-
liferative and anti-apoptotic proteins such as PCNA,
BCL-XL, and BCL-2 increased (Fig. 2d). To determine
whether hucMSC-Ex affects the cisplatin-induced inflam-
matory response in renal tubule epithelial cells, we de-
tected the expression of TNF-α by immunohistochemical
staining and IL1-β by Western blot. The results showed
that the levels of TNF-α (Fig. 2e) and IL1-β (Fig. 2f) werereduced in the hucMSC-Ex group compared to that in the
PBS group. However, HFL1-Ex showed minimal effects on
TNF-α and IL1-β expression. Taken together, these results
suggest that hucMSC-Ex can inhibit cisplatin-induced
apoptosis and secretion of inflammatory cytokines in renal
tubule epithelial cells.
hucMSC-Ex activated autophagy in vitro
Due to autophagy playing significant roles in the homeo-
stasis and physiological function of podocytes in the
kidney [24], we detected the effect of hucMSC-Ex on
activation of autophagy. NRK-52E cells were pre-treated
with hucMSC-Ex or HFL1-Ex and then exposed to cis-
platin, and autophagy-related indicators were tested. The
results of transmission electron microscopy showed
that there were a large number of autophagosomes in
hucMSC-Ex-treated cells compared with the PBS and
HFL1-Ex groups (Fig. 3a). To better illustrate the autoph-
agy puncta, we used structured illumination microscopy
(SIM) which allows us to acquire super-resolution two-
dimensional images. mRFP-GFP-LC3B NRK-52E cells
were pre-treated with hucMSC-Ex or HFL1-Ex and then
exposed to cisplatin; SIM images showed that there are a
large number of yellow and red dots in hucMSC-Ex-
treated cells compared with the PBS and HFL1-Ex groups
(Fig. 3b). hucMSC-Ex also increased the expression of
autophagy-related genes including ATG5 and ATG7 by
quantitative RT-PCR (see Additional file 3: Figure S3A
and B) (P < 0.05). The quantitative results of the integrated
density of the Western blot image showed that pre-
treatment with hucMSC-Ex increased the expression of
autophagic maker proteins such as LC3B and Beclin-1
(Fig. 3c). The mammalian target of rapamycin (mTOR)
signaling pathway plays a critical role in negatively regulat-
ing autophagy. We further demonstrated that hucMSC-Ex
inhibited the phosphorylation of mTOR and changed the
expression of its downstream targets such as 4E-BP1 and
P70S6K. The expression of 4E-BP1 was raised, and the
expression of P70S6K reduced after hucMSC-Ex adminis-
tration (Fig. 3d). In summary, these results indicate that
pre-treatment with hucMSC-Ex inhibits mTOR phos-
phorylation and activates autophagy in renal tubule epi-
thelial cells in response to cisplatin.
hucMSC-Ex prevents cisplatin-induced apoptosis and
secretion of inflammatory cytokines by activating
autophagy in vitro
Considering the critical role of autophagy in cell apop-
tosis and tissue inflammation [25, 26], we wanted to
know whether the preventative effects of hucMSC-Ex
on cisplatin-induced apoptosis and inflammatory re-
sponse are dependent on autophagy. We treated NRK-
52E cells with hucMSC-Ex in the presence or absence
of the autophagic inhibitor 3-methyladenine (3MA). As
Fig. 1 Human umbilical cord-derived mesenchymal stem cell exosomes (hucMSC-Ex) prevent deterioration of renal function in vivo. a Representative
images of renal histology (200×, scale bar = 50 μm). b The histomorphological score. c Immunohistochemical analysis of PCNA expression in kidney
tissues (200×, scale bar = 50 μm). d Percentage of proliferating cell nuclear antigen (PCNA)-positive cells. e TUNEL assay for apoptotic cells in rat renal
tissues (200×, scale bar = 50 μm). f Percentage of apoptotic cells. Serum creatinine (Cr) (g) and blood urea nitrogen (BUN) (h) levels were measured at
different times after cisplatin injection. Data are expressed as mean ± SD. *P < 0.05, n = 6. Rats treated as mentioned for the in vivo rat model were
divided into four groups as follows: 1) control; 2) phosphate-buffered saline (PBS); 3) hucMSC-Ex; and 4) human fetal lung fibroblast-1exosomes
(HFL1-Ex). All animals were sacrificed at 3 days after cisplatin injection
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increase of the autophagic marker protein LC3B and anti-
apoptotic proteins BCL-XL and BCL-2, while it reversed
the decrease of the pro-apoptotic protein Bax. However,
treatment with the autophagic inducer rapamycin mimickedthe effects of hucMSC-Ex, with an increase in LC3B, BCL-2,
and BCL-XL proteins, and a decrease in Bax protein. We
further wanted to know whether the effect of hucMSC-Ex
on inflammatory cytokines is also influenced by an autopha-
gic inhibitor. As shown in Fig. 4b, simultaneous treatment
Fig. 2 (See legend on next page.)
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Fig. 2 Human umbilical cord-derived mesenchymal stem cell exosomes (hucMSC-Ex) inhibit cisplatin-induced apoptosis and secretion of inflammatory
cytokines in NRK-52E cells in vitro. a NRK-52E cells were stained with JC-1 dye and observed under fluorescent microscopy (JC-1 produces red
fluorescence within the mitochondria as JC-1-aggregates while it emits green fluorescence when it leaks into the cytoplasm as JC-1-monomers; the shift
between green and red is proportional to the mitochondrial membrane potential change) (200×, scale bar= 50 μm). b TUNEL assay was performed to
detect the apoptotic cells (200×, scale bar= 50 μm). c Percentage of apoptotic cells. **P< 0.01, n= 3. d The expression of proliferating cell nuclear antigen
(PCNA), BCL-XL, BCL-2, Bax, Cytochrome-c, cleaved Caspase-3, and GAPDH proteins was evaluated by Western blot. e Immunohistochemical analysis of
tumor necrosis factor alpha (TNF-α) expression (200×, scale bar= 50 μm). f The expression of interleukin 1-β (IL1-β) and GAPDH proteins was evaluated by
Western blot. NRK-52E cells treated as mentioned for the in vitro experiment were divided into four groups: 1) control; 2) phosphate-buffered saline (PBS);
3) hucMSC-Ex; and 4) human fetal lung fibroblast-1exosomes (HFL1-Ex)
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cisplatin-induced IL-1β expression and NF-κB-P65 activa-
tion. Treatment with rapamycin reduced IL-1β expression
and inactivated NF-κB-P65 to that observed in hucMSC-
Ex-treated cells. The results of ELISA showed that, com-
pared to the PBS group, TNF-α levels decreased in the
hucMSC-Ex group but were restored in the hucMSC-Ex +
3MA group (Fig. 4c) (P < 0.05). Taken together, these results
demonstrated that the activation of autophagy by hucMSC-
Ex may contribute to its preventive effects on cisplatin-
induced apoptosis and the inflammatory response in vitro.
hucMSC-Ex-mediated activation of autophagy is required
for the prevention of cisplatin-induced AKI in vivo
In order to verify the activation of autophagy induced by
the hucMSC-Ex in vivo model, 3MA (500 μg/kidney)
and rapamycin (20 μg/kidney) were respectively injected
under the kidney capsule before treatment with cisplatin.
Representative images of H&E staining showed that the
number of renal tubules with edema and structural dam-
age were significantly reduced in the hucMSC-Ex group.
However, co-injection with 3MA inhibited the protective
effect of hucMSC-Ex on the renal structure. Rapamycin
had a similar effect in preventing the structural damage
of renal tubules to that of hucMSC-Ex (Fig. 5a and b).
Furthermore, the number of PCNA-positive cells in-
creased in the hucMSC-Ex group compared to the PBS
group. 3MA inhibited the effect of hucMSC-Ex. The ex-
pression of PCNA slightly increased in the rapamycin
group (Fig. 5c and d). As shown in Fig. 5e and f, the
number of TUNEL-positive cells in the hucMSC-Ex and
rapamycin groups was reduced, but showed few changes
in the hucMSC-Ex + 3MA and HFL1-Ex groups com-
pared to that in the PBS group. The results of immuno-
histochemical staining showed that TNF-α levels were
significantly lower in the hucMSC-Ex and rapamycin
groups than in the PBS group. However, TNF-α expres-
sion in the hucMSC-Ex + 3MA and 3MA groups showed
no significant difference to that in the PBS group (see
Additional file 4: Figure S4). Western blotting analyses
showed that the expression of the autophagic marker pro-
tein LC3B and anti-apoptotic protein BCL-2 increased,
while the expression of the pro-apoptotic protein Bax
decreased in the hucMSC-Ex group (Fig. 5g). However,the effects of hucMSC-Ex on these proteins were inhibited
by 3MA. Luminex assays showed that the serum levels of
the inflammatory cytokines TNF-α, IL1-β, and IL6 were
significantly lower in the hucMSC-Ex and rapamycin
groups than in the PBS group. However, their expression
in the hucMSC-Ex + 3MA group showed no significant
difference to that in the PBS group (Fig. 5h–j). Conse-
quently, these results indicate that the activation of
autophagy is involved in the preventative role of hucMSC-
Ex in cisplatin-induced AKI.
Discussion
Increasing evidence suggests that the administration of
exogenous mesenchymal stem cells (MSCs) improves
the recovery of injured tissue, including acute kidney in-
jury (AKI) [10–12, 27–31]. Several studies have demon-
strated that the administration of MSCs could reverse
kidney injury through paracrine mechanisms rather than
by MSC transdifferentiation [32, 33]. MSC exosomes
might be such a paracrine mechanism for cell-to-cell
communication. Exosomes are small vesicles released by
cells bearing the surface antigens characteristic of the
cell of origin [34, 35]. These vesicles may play critical
roles in cell communication by transferring RNA, pro-
teins, and bioactive lipids [36]. Exosomes may be more
advantageous than stem cells in regenerative medicine
due to the avoidance of possible long-term pathologic
differentiation of engrafted cells or tumor generation
[37, 38]. The release of exosomes may be constitutive, or
a consequence of cell activation by soluble agonists, or
physical and chemical stresses such as oxidative stress
and hypoxia, or by shear stress [39]. We demonstrated
in this study that pre-treatment with hucMSC-Ex could
inhibit cisplatin-induced apoptosis and the secretion of
inflammatory cytokines in renal proximal tubule epithelial
cells. hucMSC-Ex pretreatment suppressed the increase of
BUN and serum Cr levels, as well as the deterioration of
proximal tubule epithelial cells induced by cisplatin.
The role of autophagy as a degradative pathway is
critical in regenerative medicine. Many reports show that
basal or physiological autophagy contributes to the main-
tenance of cellular homeostasis and quality control of
proteins and subcellular organelles. Under pathological
conditions or cell stress, autophagy is induced which may
Fig. 3 (See legend on next page.)
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Fig. 3 Human umbilical cord-derived mesenchymal stem cell exosomes (hucMSC-Ex) induce autophagy in NRK-52E cells in response to cisplatin.
a Transmission electron microscopic examination of autophagosomes in NRK-52E cells. The representative images indicate typical autophagosomes in
the cells treated with hucMSC-Ex (scale bar = 1 μm). b SIM examination of autophagosomes in NRK-52E cells. Yellow dots represents autophagosomes,
red dots represent autolysosomes (scale bar = 5 μm). Representative images of fluorescent LC3 puncta are shown. c Western blotting analyses of the
expression of the autophagic markers LC-3B and Beclin-1 in NRK-52E cells. d NRK-52E cells were treated as indicated and the expression of mammalian
target of rapamycin (mTOR), phosphorylated mTOR, 4EBP-1, and P70S6K proteins was determined by Western blot. NRK-52E cells treated as mentioned
for the in vitro experiment were divided into four groups: 1) control; 2) phosphate-buffered saline (PBS); 3) hucMSC-Ex; and 4) human fetal lung
fibroblast-1exosomes (HFL1-Ex)
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survival. Autophagy is essential to the homeostasis and
physiological function of podocytes in the kidney [40].
Notably, autophagy induction as a self-protection mech-
anism has been demonstrated in renal tubular cells in ex-
perimental models of AKI caused by ischemia-reperfusion
and nephrotoxicants such as cisplatin and cyclosporine
[41–44]. Recent studies also report that autophagy play an
important role in MSC-promoted tissue regeneration
[45, 46]. Baixauli et al. [47] note that the emerging function
of exosomes as a means of alleviating intracellular stressFig. 4 Human umbilical cord-derived mesenchymal stem cell exosomes (huc
response by activating autophagy in vitro. a The expression of LC3B, BCL-XL,
expression of NF-κB-P65, histone, IL1-β, and GAPDH proteins was measured b
expression in NRK-52E cells. *P < 0.05, n = 3. NRK-52E cells treated as mentione
control; 2) phosphate-buffered saline (PBS); 3) hucMSC-Ex; 4) hucMSC-Ex + 3-mconditions in coordination with the autophagy-lysosomal
pathway is essential for preserving intracellular protein and
RNA homeostasis. However, whether hucMSC-Ex can
activate target cell autophagy in advance to prevent tissue
injury is not reported. Here, we found that hucMSC-
derived exosomes can induce target cell autophagy to pre-
vent nephrotoxicity in the early injury stage. In our study,
we found that hucMSC-Ex upregulated the expression of
the autophagic marker protein LC3B through the inhibition
of mTOR phosphorylation. mTOR is an evolutionarily
conserved nutrient-sensing serine/threonine protein kinase,MSC-Ex) prevent cisplatin-induced apoptosis and the inflammatory
BCL-2, Bax, and GAPDH proteins was measured by Western blot. b The
y Western blot. c ELISA analyses of tumor necrosis factor alpha (TNF-α)
d for the in vitro experiments were divided into six groups as follows: 1)
ethyladenine (3MA); 5) 3MA; and 6) rapamycin (Rapa)
Fig. 5 (See legend on next page.)
Wang et al. Stem Cell Research & Therapy  (2017) 8:75 Page 11 of 14
(See figure on previous page.)
Fig. 5 Human umbilical cord-derived mesenchymal stem cell exosomes (hucMSC-Ex) prevent apoptosis and secretion of inflammatory cytokines by
activating autophagy in vivo. a Representative images of renal histology (200×, scale bar= 50 μm). b The histomorphological score. c Immunohistochemical
analysis of PCNA expression in kidney tissues (200×, scale bar= 50 μm). d Percentage of proliferating cell nuclear antigen (PCNA)-positive cells. e TUNEL
assay for apoptotic cells in rat renal tissues (200×, scale bar= 50 μm). f Percentage of apoptotic cells. g The expression of LC3B, BCL-2, Bax, IL1-β, and
GAPDH proteins in the cisplatin-induced rat model were measured by Western blot. The serum inflammatory cytokines (h) tumor necrosis factor alpha
(TNF-α), (i) interleukin-1β (IL1-β), and (j) interleukin-6 (IL6) were measured via Luminex assay. Data are expressed as mean ± SD. *P< 0.05, n= 6. Rats were
divided into six groups as follows: 1) control; 2) phosphate-buffered saline (PBS); 3) hucMSC-Ex; 4) hucMSC-Ex + 3-methyladenine (3MA); 5) 3MA; and 6)
rapamycin (Rapa)
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tophagy [48, 49]. mTOR signaling negatively regulates au-
tophagy, and mTOR suppression by rapamycin contributes
to the induction of autophagy [50]. We found that
hucMSC-Ex downregulated the expression of phosphory-
lated mTOR and changed the levels of expression of
p70S6K and 4EBP1, suggesting that hucMSC-Ex may acti-
vate autophagy by inhibiting the mTOR signaling pathway.
In order to prove whether hucMSC-Ex-mediated au-
tophagy is essential for the inhibition of apoptosis and
secretion of inflammatory cytokines, we pre-treated
NRK-52E cells with the specific inhibitor of autophagy,
3-methyladenine (3MA). Inhibition of autophagyFig. 6 A proposed model for the mechanism of human umbilical cord-derive
against cisplatin-induced AKI. hucMSC-Ex activates autophagy and leads to th
improvement of renal recovery. 3MA 3-methyladenine, IL interleukin, mTOR m
necrosis factorreduces the effects of hucMSC-Ex on anti-apoptosis
and the inhibition of inflammatory cytokines. On the
other hand, the autophagic inducer rapamycin has a
similar effect on renal protection to that of hucMSC-Ex
both in vitro and in vivo, suggesting that induction of au-
tophagy is essential for the protective role of hucMSC-Ex
in cisplatin-induced renal injury.
From the above discussion, we propose a model as de-
lineated in Fig. 6. Cisplatin induces apoptosis and inflam-
mation in renal proximal tubule epithelial cells, resulting
in acute renal injury. hucMSC-Ex pretreatment activates
autophagy through the inhibition of the mTOR signaling
pathway in renal proximal tubule epithelial cells, leadingd mesenchymal stem cell exosome (hucMSC-Ex)-mediated protection
e reduction in cell apoptosis and inflammatory responses, and the
ammalian target of rapamycin, Rapa rapamycin, TNF tumor
Wang et al. Stem Cell Research & Therapy  (2017) 8:75 Page 13 of 14to the reduction of cell apoptosis and inflammatory re-
sponses and the improvement in renal recovery. The pre-
ventive effects of hucMSC-Ex on cisplatin-induced AKI
can be reversed by the autophagic inhibitor 3-MA. Inacti-
vation of mTOR by rapamycin mimics the effects of
hucMSC-Ex on cisplatin-induced AKI.
Conclusion
This study reveals that hucMSC-derived exosomes pre-
vent against cisplatin-induced AKI through an autophagy-
related mechanism. These findings provide a basis for the
future use of exosomes as a new biological therapeutic ap-
proach for renal diseases and injuries.
Additional files
Additional file 1: Figure S1. Characterization of hucMSCs. (A)
Immunophenotyping of hucMSC. Histograms of MSCs stained with anti-
CD13, CD44, CD29, CD90, CD105, HLA-1, CD45, HLA-DR, and CD34 shown
with an overlaid isotype control. (B) Multi-lineage differentiation of hucMSCs.
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